Company: PFSA
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112723
Chunk: 2

Company: Profusa, Inc.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
  
     3,073 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

1

PROFUSA, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE LOSS

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

    Three Months Ended September 30,  
    Nine Months Ended September 30, 

    2025  
    2024  
    2025  
    2024 
  
    Government grant revenue 
    $-  
    $75  
    $-  
    $100 
  
    Operating expenses: 

    Research and development 
     722  
     411  
     1,549  
     1,349 
  
    General and administrative 
     20,987  
     767  
     22,587  
     2,169 
  
    Total operating expenses 
     21,709  
     1,178  
     24,136  
     3,518 
  
    Loss from operations 
     (21,709) 
     (1,103) 
     (24,136) 
     (3,418)
  
    Other income (expense) 

    Gain (loss) on change in the fair value of related party convertible debt 
     258  
     (320) 
     (52) 
     (427)
  
    Gain on the change in fair value of warrant liabilities 
     884  
     —  
     884  
     — 
  
    Loss on the change in fair value of digital assets 
     (28) 
     —  
     (28) 
     — 
  
    Interest expense (including related parties amounts of $97 and $575 for the three months ended September 30, 2025 and September 30, 2024, and $1,326 and $1,774 for the nine months ended September 30, 2025 and September 30, 2024, respectively) 
     (169) 
     (1,073) 
     (2,496) 
     (3,138)
  
    Financing costs 
     (1,443)